Cargando…

Efficacy and tolerability of lamivudine in hepatitis B infected renal transplant recipients: A single center study

Hepatitis B virus (HBV) infection in patients on hemodialysis and renal transplantation (RT) usually has an unfavorable course. Lamivudine is a synthetic nucleoside analog with a potent action on HBV replication. There is limited data on lamivudine in renal transplant patients with HBV infection and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, S. K., Tiwari, S. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859485/ https://www.ncbi.nlm.nih.gov/pubmed/20436727 http://dx.doi.org/10.4103/0971-4065.57104

Ejemplares similares

Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
por: Kanda, Tatsuo, et al.
Publicado: (2011)

Reactivation of occult hepatitis B virus infection in a renal transplant recipient
por: Jiang, Lili, et al.
Publicado: (2022)

Hepatitis E Infection in a Renal Transplant Recipient
por: Vassallo, Diana, et al.
Publicado: (2014)

Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
por: Chen, En-Qiang, et al.
Publicado: (2009)

Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients
por: Lee, Heon Ju, et al.
Publicado: (2018)

Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
por: Wang, Changtai, et al.
Publicado: (2019)

Parathyroid hormone in renal transplanted recipients; a single center study
por: Nasri, Hamid, et al.
Publicado: (2013)

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
por: Kim, Jeong Han, et al.
Publicado: (2014)

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
por: Kim, Jeong Han, et al.
Publicado: (2013)

Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era
por: Moon, Ju-Young, et al.
Publicado: (2012)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
por: Park, Chan Ho, et al.
Publicado: (2016)

Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review
por: Zhao, Shushan, et al.
Publicado: (2010)

Lamivudine Therapy for Korean Children with Chronic Hepatitis B
por: Koh, Hong, et al.
Publicado: (2007)

Infection in Renal Transplant Recipients
por: Kotton, Camille Nelson, et al.
Publicado: (2010)

Infection in Renal Transplant Recipients
por: Fishman, Jay A., et al.
Publicado: (2008)

Infection in Renal Transplant Recipients
por: Fishman, Jay A., et al.
Publicado: (2005)

Infection in Renal Transplant Recipients
por: Sawinski, Deirdre, et al.
Publicado: (2019)

Profile of infections in renal transplant recipients from India
por: Kumar, Arun, et al.
Publicado: (2016)

Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation
por: Lee, Jae Geun, et al.
Publicado: (2015)

Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience
por: Abu Jawdeh, Bassam G., et al.
Publicado: (2017)

BK polyomavirus infection following COVID-19 infection in renal transplant recipients: a single-center experience
por: Meshram, Hari Shankar, et al.
Publicado: (2021)

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
por: Jeon, Hee-Jeong, et al.
Publicado: (2017)

Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
por: Argani, Hassan, et al.
Publicado: (2004)

Entecavir and lamivudine therapy for severe acute chronic hepatitis B
por: LIU, CHANGHONG, et al.
Publicado: (2013)

High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B
por: Wani, Hamid Ullah, et al.
Publicado: (2014)

Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study
por: Artan, Ayşe Serra, et al.
Publicado: (2023)

1757. Hepatitis C-Infected Donors and Hepatitis C-Infected Recipients: Analysis of Renal Transplant Outcomes
por: Crossman, Hayley, et al.
Publicado: (2019)

Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B Virus
por: Kim, Kang Mo, et al.
Publicado: (2005)

Virus infections in renal transplant recipients.
por: Mallick, N. P., et al.
Publicado: (1981)

Viral Infection in Renal Transplant Recipients
por: Cukuranovic, Jovana, et al.
Publicado: (2012)

COVID-19 in Renal Transplant Recipients – A Single Center Experience from India
por: Jha, Pranaw Kumar, et al.
Publicado: (2022)

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
por: Hwang, Joo An, et al.
Publicado: (2015)

Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China
por: Wu, Ya-Song, et al.
Publicado: (2016)

Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis
por: Sali, Shahnaz, et al.
Publicado: (2019)

Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
por: Wang, Zhao, et al.
Publicado: (2011)

Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
por: Kim, Jihyun, et al.
Publicado: (2015)

Parvovirus B19 Infection and Severe Anemia in Renal Transplant Recipients
por: Carraturo, Antonio, et al.
Publicado: (2012)

Prevalence of occult hepatitis B virus infection in kidney transplant recipients
por: Franz, Cibele, et al.
Publicado: (2013)

Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study
por: Darema, Maria, et al.
Publicado: (2020)

Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections
por: Lin, Ming-Tsung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dlaffdpkac6rs7l0j4qb4ks2ok